Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability

RESOLVED

What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.

Priority: 0.92 Domain: neurodegeneration Hypotheses: 2

📊 Landscape Analysis

Landscape Summary: Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability is a 0.92 priority gap in neurodegeneration. It has 2 linked hypotheses with average composite score 0.640. Status: resolved.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.642

Top Score

0.640

Avg Score

Debates

0.00

Avg Quality

100%

Resolution

Mechanistic Families

Gap Resolution Progress100%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding

Target: CSGA Pathway: Bacterial curli amyloid → α-sy

0.642

score

Selective Neuronal Vulnerability Network Targeting

Target: Cell-type specific vulnerability markers Pathway: N/A

0.638

score

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

📈 Selective Neuronal Vulnerability Network Targeting score=0.638 2026-04-04T13:37

📈 Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro score=0.642 2026-04-02T20:53

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps